![]() |
Volumn 343, Issue 1, 2010, Pages 17-23
|
Synthesis and antiproliferative activitiy of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group
|
Author keywords
4H pyrido 1,2 a pyrimidin 4 one; Antiprofilerative activity; Synthesis
|
Indexed keywords
1 (2 FLUOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (2 FLUOROPHENYL) 3 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY) PHENYL)UREA;
1 (2,6 DIFLUOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (2,6 DIFLUOROPHENYL) 3 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (2,6 DIFLUOROPHENYL) 3 (4 (4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 3 YL)PHENYL)UREA;
1 (3 CHLORO 4 FLUOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (3 CHLORO 4 FLUOROPHENYL) 3 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (3 FLUOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (3 FLUOROPHENYL) 3 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (3 FLUOROPHENYL) 3 (4 (4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 3 YL)PHENYL)UREA;
1 (3,5 DICHLOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL) 3 (3 (TRIFLUOROMETHYL)PHENYL)UREA;
1 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL) 3 (3 (TRIFLUOROMETHYL)PHENYL)UREA;
1 (4 FLUOROPHENYL) 3 (4 ((4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
1 (4 FLUOROPHENYL) 3 (4 ((8 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 2 YL)METHOXY)PHENYL)UREA;
2 ((4 AMINOPHENOXY)METHYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
2 ((4 AMINOPHENOXY)METHYL) 8 METHYL 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
2 ((4 NITROPHENOXY)METHYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
2 (CHLOROMETHYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
2 (CHLOROMETHYL) 8 METHYL 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
3 (4 AMINOPHENYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
3 (4 NITROPHENYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
4 PYRIMIDINONE DERIVATIVE;
8 METHYL 2 ((4 NITROPHENOXY)METHYL) 4H PYRIDO[1,2 A]PYRIMIDIN 4 ONE;
ANTINEOPLASTIC AGENT;
ETHYL 2 (4 NITROPHENYL)ACETATE;
ETHYL 3 (DIMETHYLAMINO) 2 (4 NITROPHENYL)ACRYLATE;
SORAFENIB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UREA DERIVATIVE;
DRUG DERIVATIVE;
PYRIMIDINONE DERIVATIVE;
UREA;
ARTICLE;
BREAST CANCER;
CANCER CELL CULTURE;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
CELL PROLIFERATION;
DRUG EFFECT;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
PYRIMIDINONES;
STRUCTURE-ACTIVITY RELATIONSHIP;
UREA;
|
EID: 74949121528
PISSN: 03656233
EISSN: 15214184
Source Type: Journal
DOI: 10.1002/ardp.200900130 Document Type: Article |
Times cited : (20)
|
References (14)
|